Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-65,800
Closed -$10.7M 2755
2015
Q4
$10.7M Buy
65,800
+21,300
+48% +$3.35M 0.18% 54
2015
Q3
$6.16M Buy
44,500
+13,200
+42% +$2.08M 0.1% 107
2015
Q2
$4.8M Sell
31,300
-2,800
-8% -$449K 0.09% 139
2015
Q1
$5.45M Sell
34,100
-6,800
-17% -$1.07M 0.11% 109
2014
Q4
$6.51M Sell
40,900
-5,000
-11% -$779K 0.11% 94
2014
Q3
$6.45M Sell
45,900
-17,000
-27% -$2.22M 0.12% 99
2014
Q2
$7.45M Sell
62,900
-24,500
-28% -$2.84M 0.12% 101
2014
Q1
$10.8M Buy
87,400
+30,600
+54% +$3.71M 0.13% 100
2013
Q4
$6.48M Sell
56,800
-5,100
-8% -$580K 0.07% 167
2013
Q3
$6.93M Buy
+61,900
New +$6.71M 0.09% 148

Other funds holding AMGN

Virtu KCG Holdings's AMGN Position: Q2 2017 in Review

Virtu KCG Holdings increased its Amgen (AMGN) stake by 18% in Q2 2017, buying an estimated $678K and bringing the position to 26,738 shares worth $4.61M. The position accounts for 0.13% of the portfolio, ranked #70.

Virtu KCG Holdings first reported a position in AMGN in Q3 2013 and has held it in 16 quarters since. The position peaked at $13.2M in Q3 2016. 1,595 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

  • Virtu KCG Holdings held 26,738 shares of Amgen worth $4.61M as of Q2 2017.
  • Virtu KCG Holdings bought 4,168 Amgen shares in Q2 2017, an estimated $678K.
  • Amgen made up 0.13% of Virtu KCG Holdings's portfolio in Q2 2017, its #70 holding.
  • Virtu KCG Holdings first reported a position in Amgen in Q3 2013 and has held it in 16 quarters since.
  • Virtu KCG Holdings's Amgen position peaked at $13.2M in Q3 2016.
  • 1,595 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.